COVID-19, the disease caused by SARS-CoV-2, has been disruptive worldwide. It was primarily a respiratory disease that affected many of the medically vulnerable, but the true impact of postacute sequelae of SARS-CoV-2 (PASC), which has been demonstrated to involve all organ systems, is now coming to light.
Our recent issue COVID-19, MIS-C, and Long COVID in Pediatric Patients: An Update reviews the presentation, evaluation, and management of patients with COVID-19, MIS-C, and PASC. Additionally, the current literature supporting public health measures, as well as COVID-19 vaccinations and their complications are discussed.
Test Your Knowledge
Did you get it right? Click here to find out!
Ready to learn more? Log in to check out our recent issue COVID-19, MIS-C, and Long COVID in Pediatric Patients: An Update.
USACS subscribers can log in or renew here.
You can earn 4 AMA PRA Category 1 Credits™ by answering just 9 more questions! Subscribe today to review the issue and complete the 10-question quiz.
Here are a few key points:
- SARS-CoV-2 typically leads to a less severe infection in children than in adults.11,12 (See Table 1 in the issue.)
- It is important to ascertain the patient‘s exposure to COVID-19–positive contacts and COVID-19 vaccination history.
- Children who should be evaluated immediately include infants aged <2 months with fever and older children with >3 days of fever, respiratory distress, or any sign of organ dysfunction, including decreased urine output.13
- If patients with COVID-19 are well-appearing with only upper respiratory symptoms and fever, no laboratory studies are necessary.
Read the full issue and earn 4 AMA PRA Category 1 Credits™.
